HD12 randomised trial comparing 8 dose-escalated cycles of BEACOPP with 4 escalated and 4 baseline cycles in patients with advanced stage Hodgkin lymphoma (HL): An analysis of the german Hodgkin lymphoma study group (GHSG), University of Cologne, D-50924 Cologne, Germany.

被引：0
|
作者：
Engert, Andreas
Franklin, Jeremy
Mueller, Rolf-Peter
Eich, Hans-Theodor
Gossmann, Axel
Mueller-Hermelink, Hans Konrad
Cemy, Thomas
Markova, Jana
Ho, Anthony D.
Kanz, Lothar
Greil, Richard
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp Cologne, Coordinat Ctr Clin Trials, Cologne, Germany
[3] Univ Hosp Cologne, Dept Radiotherapy, Cologne, Germany
[4] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[5] Dept Internal Med, St Gallen, Switzerland
[6] Prague Univ, Dept Hematol, Prague, Czech Republic
[7] Univ Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany
[8] Univ Tubingen, Dept Internal Med, D-7400 Tubingen, Germany
[9] Salzburg Univ, Dept Internal Med 3, A-5020 Salzburg, Austria
[10] Univ Hosp Munich, Dept Internal Med 3, Munich, Germany
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
99
引用
收藏
页码：33A / 33A
页数：1
相关论文
共 26 条
  • [21] Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study
    Belada, David
    Stepankova, Pavla
    Sykorova, Alice
    Zak, Pavel
    Smolej, Lukas
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 2013 - 2018
  • [22] ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N.
    Brice, P.
    Bologna, S.
    Briere, J.
    Gaillard, I.
    Heczko, M.
    Gabarre, J.
    Casasnovas, O.
    Jaubert, J.
    Colin, P.
    Delmer, A.
    Devidas, A.
    Bachy, E.
    Nicolas-Virelizier, E.
    Aoudjhane, A.
    Humbrecht, C.
    Andre, M.
    Carde, P.
    ANNALS OF ONCOLOGY, 2014, 25 (08) : 1622 - 1628
  • [23] 8X BEACOPPESC COMPARED TO 4X BEACOPPESC FOLLOWED BY 4X BEACOPPBASE WITH OUR WITHOUT RADIOTHERAPY FOR ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: FINAL ANALYSIS OF THE HD12 TRIAL OF THE GERMAN HODGKIN STUDY GROUP
    Borchmann, P.
    Haverkamp, H.
    Mueller, R. -P.
    Eich, H. -T
    Mueller-Hermelink, H. K.
    Cerny, T.
    Markova, J.
    Ho, A. D.
    Kanz, L.
    Greil, R.
    Hiddemann, W.
    Engert, A.
    Diehl, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 437 - 437
  • [24] A contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stage Hodgkin's lymphoma - Fourth interim analysis of the multicenter randomized trial HD12 of the German Hodgkin study group (GHSG)
    Eich, H. T.
    Mueller, R. P.
    Brillant, C.
    Engert, A.
    Franklin, J.
    Hansemann, K.
    Skripnitchenko, R.
    Staar, S.
    Pfistner, B.
    Diehl, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S96 - S97
  • [25] Combined modality treatment of two or four cycles of ABVD followed by involved field radiotherapy in the treatment of patients with early stage Hodgkin's lymphoma: Update interim analysis of the randomised HD10 study of the German Hodgkin study group (GHSG).
    Engert, A
    Pluetschow, A
    Eich, HT
    Herrmann, R
    Doerken, B
    Kanz, L
    Greil, R
    Markova, J
    Pfistner, B
    Josting, A
    Mueller-Hermelink, K
    Mueller, RP
    Diehl, V
    BLOOD, 2005, 106 (11) : 750A - 750A
  • [26] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) is the New Standard of Care in the Treatment of Patients with Early Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) Trial HD10
    Mueller, R. P.
    Eich, H. T.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilbom, K.
    Eble, M.
    Mueller-Hennelink, H.
    Diehl, V.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S26 - S27
123